NRX Pharmaceuticals Inc
Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Nov 14, 2024
NRXP$2.38+4.8%Stored close · as of Nov 6, 2026
Contents
PROSPECTUS
We have not authorized any dealer, salesperson or other person to give any information or to make any representations not contained in this prospectus. You must not rely on any unauthorized information. This prospectus is not an offer to sell these securities in any jurisdiction where an offer or sale is not permitted.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.